FemTherapeutics is a biotechnology company focused on developing novel therapeutics for female reproductive health. The company leverages its proprietary drug delivery platform to address unmet medical needs in women's health, with an emphasis on non-hormonal treatments for conditions like uterine fibroids and endometriosis.

Inara Lalani

Mihnea Gangal

Negin Ashouri

FemTherapeutics

FemTherapeutics is a medical device company developing “Invisalign for Gynaecology”. Leveraging artificial intelligence and 3D Printing, our gynaecology platform offers patient-specific intra-vaginal devices for common pelvic health conditions. Our first product is a custom pessary for the management of Pelvic Organ Prolapse and Stress Urinary Incontinence, which affects 50% of women during their lifetime. FemTherapeutics is building the infrastructure to allow expansion into other pelvic health categories including menstruation and sexual wellness, labor and delivery, oncology, and more. 

Ministère de l'Économie et de l'Innovation

Centech

Fonds de solidarité FTQ

Natural Sciences and Engineering Research Council of Canada (NSERC)

McGill University

Mitacs

Montréal inc.

Mouvement des accelerateurs d'innovation du Quebec

National Research Council Canada

Investissement Quebec

SheBoot

The 51 Ventures

2048 Ventures

FemTherapeutics Inc.

Metric
Company Name	FemTherapeutics
Symbol
MSH ID	COM:FEMTHERAPEUTICS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	CA
Stage
Employee Count	15
Website	femtherapeutics.com
LinkedIn	femtherapeutics
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:FEMTHERAPEUTICS

FemTherapeutics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue